NR3C1 and fatty liver disease: Glucocorticoid receptor β could induce hepatic steatosis via inflammation activation (Marino et al., 2016), and selective regulation on glucocorticoid receptor could reverse and prevent nonalcoholic fatty liver disease in mice models (Koorneef et al., 2018).